ANRS Infectious emerging diseases (MIE), autonomous agency of Inserm, facilitates, evaluates, coordinates and funds research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases.
A central role in infectious diseases research for over 35 years
Supporting research to prevent, understand and treat infectious diseases
ANRS MIE three majors levels of action
ANRS MIE is an agency operating under the specific status of an autonomous agency within Inserm.
Patient associations, next generation of scientists, quality and ethical approach, open science
Our agency funds, coordinates, evaluates and facilitates research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging infectious diseases.
Learn more about the diseases and pathogens covered by our research
Information on the projects we fund
Our workgroups bring together researchers and representatives of civil society
Guiding and advising innovative project leaders
The agency supports a number of research platforms and networks to federate and help shape research in its field
National and international research platforms supported by the agency and designed for the scientific community
Clinical research networks and networks of young researchers
Access to data and biological collections from research promoted by the agency
The agency is a member of various networks and forges partnerships with national and international associations, organisations and initiatives
Partner sites, international global health research platforms, ad hoc partnerships
WHO, Ministry of Europe and Foreign Affairs, Global Health EDCTP3 Joint Undertaking, structuring networks
Strategic international projects and capacity-building programmes
Fighting epidemics: ANRS MIE leads WHO filovirus CORC
Collaboration with community stakeholders
Each year, the agency offers two calls for generic projects and calls for thematic projects. Some are jointly carried out with other research players
Agency's current, forthcoming and completed calls for proposals
Find out the list of calls for projects previously funded by the agency
Find out the Start programme, here to support and guide the next generation of scientific researchers
ANRS MIE is at the forefront of crisis preparedness and response.
Facilitation and watch procedure for responding to emerging or re-emerging epidemics.
ANRS MIE continues to follow influenza closely since June 2024.
This Outbreak Response Unit for several diseases is active since March 2025.
Opened since January 2025 and still active since the detection of one new case in French Guiana in January 2026.
A level 1 Outbreak Response Unit since December 2023, monitoring new cases in Mayotte and La Réunion.
Discover every Outbreak Response units.
Submit a project
Here you can find all the latest news and events relating to our areas of research.
Share:
Trier par
Congress of the ESCMID 2026 will take place from April 17 to 21, 2026, in Munich, Germany.
26 June 2026 - Paris
The authorisation and availability in France of cabotegravir (Apretude®) in injectable form represent a major innovation in pre-exposure prophylaxis (PrEP) and the prevention of HIV/AIDS.
The PROACT EU-Response, Open ReMIE and STRIVE initiatives came together for the first inter-platform meeting on therapeutic clinical research.
To mark the One Health Summit 2026, ANRS MIE, CEPI and the WHO have published R&D roadmaps to tackle the next pandemic.
The One Health Summit will take place from april 5 to 7, 2026, in Lyon, France.
The ANRS MIE Scientific Days will take place on 1 and 2 April 2026 at the Cité internationale universitaire de Paris, France.
The ANRS MIE's Coordinated Action "Host-HIV interactions, basic and translational research" is renewing its work in progress (WIP) meeting for the 7th consecutive year.
